Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	44.91B
Revenue (ttm)	12.70B
Net Income (ttm)	1.87B
Shares Out	1.77B
EPS (ttm)	1.06
PE Ratio	25.61
Forward PE	24.80
Dividend	0.20 (0.74%)
Ex-Dividend Date	Jul 4, 2025

Volume	90,320,743
Average Volume	29,021,493
Open	24.36
Previous Close	25.10
Day's Range	24.36 - 27.34
52-Week Range	18.42 - 36.42
Beta	0.90
RSI	70.49
Earnings Date	Aug 22, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.